Resultados de procura - Gordon Rustin

Limitar resultados
  1. 1
    True

    True por Tim Meyer, Gordon Rustin

    Publicado 2000
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    CA125 Response: Can it Replace the Traditional Response Criteria in Ovarian Cancer?

    CA125 Response: Can it Replace the Traditional Response Criteria in Ovarian Cancer? por Amy Guppy, Gordon Rustin

    Publicado 2002
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours.

    Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours. por Gordon Rustin, Margaret Booth, J. Dent, Sandra Salt, Frances Rustin, K. D. Bagshawe

    Publicado 1984
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Successful management of metastatic and primary germ cell tumors in the brain

    Successful management of metastatic and primary germ cell tumors in the brain por J. S. Gordon Rustin, E.S. Newlands, Kenneth D. Bagshawe, H. J. RICHARD Begent, S. M. Crawford

    Publicado 1986
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysis

    Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysis por Susan Galbraith, Martin A. Lodge, N. Jane Taylor, Gordon Rustin, Søren M. Bentzen, James Stirling, Anwar R. Padhani

    Publicado 2002
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial

    A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical researc... por Graham M. Mead, M.H. Cullen, Robert Huddart, Peter Harper, Gordon Rustin, Pat Cook, Sally Stenning, Malcolm D. Mason

    Publicado 2005
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Gestational and nongestational trophoblastic tumors distinguished by DNA analysis

    Gestational and nongestational trophoblastic tumors distinguished by DNA analysis por Rosemary A. Fisher, Edward S. Newlands, A. J. Jeffreys, Geoffrey M. Boxer, Richard H. J. Beǵent, Gordon Rustin, Kenneth D. Bagshawe

    Publicado 1992
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    The efficacy of audiotapes in promoting psychological well-being in cancer patients: a randomised, controlled trial

    The efficacy of audiotapes in promoting psychological well-being in cancer patients: a randomised, controlled trial por Patrick McHugh, Shôn Lewis, Sarah Ford, E.S. Newlands, Gordon Rustin, R. Charles Coombes, Dean Smith, Séamus O’Reilly, Lesley Fallowfield

    Publicado 1995
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Randomized Trial of Two or Five Computed Tomography Scans in the Surveillance of Patients With Stage I Nonseminomatous Germ Cell Tumors of the Testis: Medical Research Council Trial TE08, ISRCTN56475197—The National Cancer Research Institute Testis Cancer Clinical Studies Group

    Randomized Trial of Two or Five Computed Tomography Scans in the Surveillance of Patients With Stage I Nonseminomatous Germ Cell Tumors of the Testis: Medical Research Council Tria... por Gordon Rustin, Graham M. Mead, Sally Stenning, P. Vasey, Nina Aass, Robert Huddart, M. Sokal, J. K. Joffe, Stephen Harland, S Kirk

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Secondary tumours following etoposide containing therapy for germ cell cancer

    Secondary tumours following etoposide containing therapy for germ cell cancer por Chris Boshoff, Richard H. J. Beǵent, R.T.D. Oliver, Gordon Rustin, ES Newlands, RG Andrews, Matthew R. Skelton, L. Holden, J. Ong

    Publicado 1995
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Targeted anti-vascular therapies for ovarian cancer: current evidence

    Targeted anti-vascular therapies for ovarian cancer: current evidence por Marcia Hall, Charlie Gourley, Iain A. McNeish, Jonathan A. Ledermann, Martin Gore, Gordon C. Jayson, Timothy Perren, Gordon Rustin, Stan B. Kaye

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  12. 12
    5,6-Dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent: phase I clinical and pharmacokinetic study

    5,6-Dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent: phase I clinical and pharmacokinetic study por Gordon Rustin, Christopher Bradley, Susan Galbraith, M.R.L. Stratford, Paul M. Loadman, S. Waller, K Bellenger, Lindsey Gumbrell, Lisa K. Folkes, Gavin Halbert

    Publicado 2003
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Malignant Ovarian Germ Cell Tumors: Identification of Novel Prognostic Markers and Long-Term Outcome After Multimodality Treatment

    Malignant Ovarian Germ Cell Tumors: Identification of Novel Prognostic Markers and Long-Term Outcome After Multimodality Treatment por Nirupa Murugaesu, Peter Schmid, Gairin Dancey, Roshan Agarwal, L. Holden, Iain A. McNeish, Philip Savage, E.S. Newlands, Gordon Rustin, Michael J. Seckl

    Publicado 2006
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Use of CA-125 in Clinical Trial Evaluation of New Therapeutic Drugs for Ovarian Cancer

    Use of CA-125 in Clinical Trial Evaluation of New Therapeutic Drugs for Ovarian Cancer por Gordon Rustin, Robert C. Bast, Gary J. Kelloff, J. Carl Barrett, Stephen K. Carter, Perry D. Nisen, Caroline C. Sigman, David Parkinson, Raymond W. Ruddon

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  15. 15
    Comparison of CA-125 and Standard Definitions of Progression of Ovarian Cancer in the Intergroup Trial of Cisplatin and Paclitaxel Versus Cisplatin and Cyclophosphamide

    Comparison of CA-125 and Standard Definitions of Progression of Ovarian Cancer in the Intergroup Trial of Cisplatin and Paclitaxel Versus Cisplatin and Cyclophosphamide por Gordon Rustin, P.J. Timmers, Ann E. Nelstrop, Gavin Shreeves, Søren M. Bentzen, Benoît Baron, Martine Piccart, K. Bertelsen, Gavin Stuart, James T. Cassidy, Elizabeth A. Eisenhauer

    Publicado 2005
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer

    A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer por Gordon Rustin, Gavin Shreeves, Paul Nathan, Andrew Gaya, Trivadi S. Ganesan, D Wang, J Boxall, L. Poupard, David J. Chaplin, M.R.L. Stratford, Jai Balkissoon, Martin Zweifel

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS)

    Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS) por Ajay K. Kakkar, Mark N. Levine, Zbigniew Kadziola, Nicholas R. Lemoine, V. Warren Low, Heman K. Patel, Gordon Rustin, Michael J. Thomas, Mary Quigley, R C N Williamson

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Re: New Guidelines to Evaluate the Response to Treatment in Solid Tumors (Ovarian Cancer)

    Re: New Guidelines to Evaluate the Response to Treatment in Solid Tumors (Ovarian Cancer) por Gordon Rustin, Michael Quinn, Tate Thigpen, Andreas du Bois, Éric Pujade-Lauraine, Anders Jakobsen, Elizabeth A. Eisenhauer, Satoru Sagae, Kathryn M. Greven, Ignace Vergote, Andrés Cervantes, Jan B. Vermorken

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Carta
    Engadir a favoritos
    Gardado en:
  19. 19
    Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer

    Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer por Martin Zweifel, Gordon C. Jayson, N.S. Reed, Richard H. Osborne, Bassam Abdul Rasool Hassan, Jonathan A. Ledermann, Gavin Shreeves, L. Poupard, S.-P. Lu, Jai Balkissoon, David J. Chaplin, Gordon Rustin

    Publicado 2011
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    O6-Methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma

    O6-Methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma por MR Middleton, JM Lunn, C. Morris, Gordon Rustin, Stephen R. Wedge, MH Brampton, MJ Lind, Siow Ming Lee, David R. Newell, N M Bleehen, ES Newlands, A. Hilary Calvert, GP Margison, Nicholas Thatcher

    Publicado 1998
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: